174 related articles for article (PubMed ID: 8701813)
1. Molecular research in cancer: future clinical applications.
Ratliff TL
Acta Urol Belg; 1996 May; 64(2):53-5. PubMed ID: 8701813
[No Abstract] [Full Text] [Related]
2. Gene therapy approaches in urologic oncology.
Vieweg J; Gilboa E
Surg Oncol Clin N Am; 1995 Apr; 4(2):203-18. PubMed ID: 7796281
[TBL] [Abstract][Full Text] [Related]
3. The immunotherapy of prostate and bladder cancer.
Totterman TH; Loskog A; Essand M
BJU Int; 2005 Oct; 96(5):728-35. PubMed ID: 16144528
[TBL] [Abstract][Full Text] [Related]
4. Autologous neoplastic isto-cryoprecipitates as immuno-stimulating treatment in 100 urological cancer patients.
Marten-Perolino R; Cocimano V; Botto A; Buffa G; Riggi E; Trapani C
J Exp Pathol; 1987; 3(4):587-92. PubMed ID: 3454806
[No Abstract] [Full Text] [Related]
5. Molecular engineering of the antitumor immune response.
Pardoll DM; Golumbek P; Levitsky H; Jaffee L
Bone Marrow Transplant; 1992; 9 Suppl 1():182-6. PubMed ID: 1387016
[No Abstract] [Full Text] [Related]
6. Ovarian tumour antigens as potential targets for immune gene therapy.
Kuiper M; Peakman M; Farzaneh F
Gene Ther; 1995 Jan; 2(1):7-15. PubMed ID: 7712335
[TBL] [Abstract][Full Text] [Related]
7. HLA class II restricted T-cell receptor gene transfer generates CD4+ T cells with helper activity as well as cytotoxic capacity.
van der Veken LT; Hoogeboom M; de Paus RA; Willemze R; Falkenburg JH; Heemskerk MH
Gene Ther; 2005 Dec; 12(23):1686-95. PubMed ID: 16034453
[TBL] [Abstract][Full Text] [Related]
8. Structural basis of antigen recognition by T lymphocytes. Implications for vaccines.
Berzofsky JA
J Clin Invest; 1988 Dec; 82(6):1811-7. PubMed ID: 2974044
[No Abstract] [Full Text] [Related]
9. Basic overview of current immunotherapy approaches in urologic malignancy.
Drake CG
Urol Oncol; 2006; 24(5):413-8. PubMed ID: 16962493
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapy of prostate cancer.
Doehn C
Eur Urol; 2008 Apr; 53(4):681-3; discussion 684-5. PubMed ID: 18248878
[No Abstract] [Full Text] [Related]
11. [Peptide-pulsed dendritic cell therapy].
Takaue Y; Tanosaki R; Tobisu K
Nihon Rinsho; 2000 Jul; 58 Suppl():295-8. PubMed ID: 11022733
[No Abstract] [Full Text] [Related]
12. Genetically modified tumour vaccines--where we are today.
Nawrocki S; Mackiewicz A
Cancer Treat Rev; 1999 Feb; 25(1):29-46. PubMed ID: 10212588
[TBL] [Abstract][Full Text] [Related]
13. [Molecular targets for development of cancer immunotherapy].
Kawakami Y
Nihon Rinsho; 2012 Nov; 70 Suppl 8():144-8. PubMed ID: 23513828
[No Abstract] [Full Text] [Related]
14. The systemic therapy of urologic cancer.
Marsh JC
Conn Med; 1980 Apr; 44(4):217-24. PubMed ID: 7371401
[No Abstract] [Full Text] [Related]
15. [Immunotherapy of invasive cancer of the urinary bladder].
Kharchenko VP; Kaprin AD; Ivanov SA; Klimenko AA
Vopr Onkol; 2006; 52(6):659-62. PubMed ID: 17338244
[No Abstract] [Full Text] [Related]
16. Advances in specific immunotherapy for prostate cancer.
Kiessling A; Füssel S; Wehner R; Bachmann M; Wirth MP; Rieber EP; Schmitz M
Eur Urol; 2008 Apr; 53(4):694-708. PubMed ID: 18061335
[TBL] [Abstract][Full Text] [Related]
17. Dendritic cells for specific cancer immunotherapy.
Meidenbauer N; Andreesen R; Mackensen A
Biol Chem; 2001 Apr; 382(4):507-20. PubMed ID: 11405216
[TBL] [Abstract][Full Text] [Related]
18. Specific antitumor immune response induced by a novel DNA vaccine composed of multiple CTL and T helper cell epitopes of prostate cancer associated antigens.
Qin H; Zhou C; Wang D; Ma W; Liang X; Lin C; Zhang Y; Zhang S
Immunol Lett; 2005 Jun; 99(1):85-93. PubMed ID: 15894116
[TBL] [Abstract][Full Text] [Related]
19. Prospects and limitations of recombinant poxviruses for prostate cancer immunotherapy.
Hwang C; Sanda MG
Curr Opin Mol Ther; 1999 Aug; 1(4):471-9. PubMed ID: 11713762
[TBL] [Abstract][Full Text] [Related]
20. Recognition of prostate and melanoma tumor cells by six-transmembrane epithelial antigen of prostate-specific helper T lymphocytes in a human leukocyte antigen class II-restricted manner.
Kobayashi H; Nagato T; Sato K; Aoki N; Kimura S; Murakami M; Iizuka H; Azumi M; Kakizaki H; Tateno M; Celis E
Cancer Res; 2007 Jun; 67(11):5498-504. PubMed ID: 17545632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]